-
Mashup Score: 0
Miguel Ferreira, MSc of GlobalData discusses how the Hodgkin’s lymphoma market to suffer with Adcetris patent expiry but benefit from new competitive landscape, says GlobalData. Adcetris is the world’s 7MM * (US, 5EU and Japan) market-leading drug and has been the major contributor to the market development of Hodgkin’s lymphoma (HL) in recent years. In this currently rising market, the initial…
Source: www.oncologytube.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
Miguel Ferreira, MSc @globaldataplc #hodgkinslymphoma Hodgkin’s lymphoma market to suffer with Adcetris patent expiry but benefit from new competitive landscape, says GlobalData https://t.co/EM7pVHw2Jo https://t.co/GXK8BoFcvg